Discontinued — last reported Q3 '25
Insmed Number of Operating Segments increased by 300.0% to $1.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 300.0%, from $0.25 to $1.00. Over 3 years (FY 2021 to FY 2025), Number of Operating Segments shows relatively stable performance with a 0.0% CAGR.
An increase may signal diversification or acquisition activity, while a decrease suggests business simplification or divestiture.
The total number of reportable business segments identified by the company for financial reporting purposes. This reflec...
Standard disclosure in segment reporting notes for diversified public companies.
cvx_number_of_operating_segments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +300.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — | — | — | — | +300.0% |